Neuroscientific Biopharmaceuticals Ltd

Research Neuroscientific Biopharmaceuticals Ltd (NSB) on Bullrun: market cap AUD 19.95M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNSB
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyAUD
• Market capAUD 19.95M
• Financial periodFY2025
• Net income-AUD 1.85M
• Free cash flow-AUD 941.33K

Valuation Snapshot

latest market cap is AUD 19.95M.

About Neuroscientific Biopharmaceuticals Ltd

NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia.

Frequently asked questions

What is Neuroscientific Biopharmaceuticals Ltd's market cap?

Neuroscientific Biopharmaceuticals Ltd's market capitalization is AUD 19.95M.

What does Neuroscientific Biopharmaceuticals Ltd do?

NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma.